News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nyrada.
RELATED STOCKHEAD STORIES
News
ASX February winners: The best 50 stocks as a ‘super-heroic small cap’ soars 322%
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Buyers ambush benchmark setting new benchmark
Health & Biotech
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX200 flat and earthbound as Nyrada CEO exclusively shares 3 reasons for stunning +420pc session
News
ASX Small Caps Lunch Wrap: ASX is flat for now but inflation is chill and lithium is spiffium again
News
Top 10 at 11: Which biotechs are up after positive study results and deals?
Health & Biotech
ASX Health Stocks: Neuren’s sales come in at top of guidance range, crushing short seller’s claims
News
In Case You Missed It: R&D refunds for drug developers and a major uranium merger
News
Closing Bell: The ASX is slightly higher, but not much cooler on Monday
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Bad week for benchmark; signals of a Sino solution, however, if Albo is able
Health & Biotech
Strokes cost the Australian economy billions, but these biotech players could change that
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX falls flat after strong employment data muddies waters
News
